Continuous positive airway pressure versus high-flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: A randomized controlled trial.
Nagata K, Yokoyama T, Tsugitomi R, Nakashima H, Kuraishi H, Ohshimo S, Mori Y, Sakuraya M, Kagami R, Tanigawa M, Tobino K, Kamo T, Kadowaki T, Koga Y, Ogata Y, Nishimura N, Kondoh Y, Taniuchi S, Shintani A, Tomii K; JaNP-Hi Study Investigators.
Respirology. 2024 Jan;29(1):36-45. doi: 10.1111/resp.14588. Epub 2023 Aug 30.
PMID:37648252
Timing of surfactant treatment in respiratory distress syndrome.
High flow nasal cannula therapy versus continuous positive airway pressure and nasal positive pressure ventilation in infants with severe bronchiolitis: a randomized controlled trial.
Borgi A, Louati A, Ghali N, Hajji A, Ayari A, Bouziri A, Hssairi M, Menif K, Benjaballah N.
Pan Afr Med J. 2021 Nov 3;40:133. doi: 10.11604/pamj.2021.40.133.30350. eCollection 2021.
PMID:34909101
European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update.
Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A, Plavka R, Roehr CC, Saugstad OD, Simeoni U, Speer CP, Vento M, Visser GHA, Halliday HL.
High continuous positive airway pressures versus non-invasive positive pressure ventilation in preterm neonates: protocol for a multicentre pilot randomised controlled trial.
Mukerji A, Rempel E, Thabane L, Johnson H, Schmolzer G, Law BHY, Jani P, Tracy M, Rottkamp C, Keszler M, Kirpalani H, Shah PS; NOVEL Trial Group.
BMJ Open. 2023 Feb 14;13(2):e069024. doi: 10.1136/bmjopen-2022-069024.
PMID:36787974
Community continuous positive airway pressure therapy and non-invasive ventilation use during the COVID-19 pandemic.
Chiang KY, Ip MSM, Lui MMS.
Hong Kong Med J. 2021 Feb;27(1):64-66. doi: 10.12809/hkmj208658. Epub 2021 Feb 2.